Search results for "national database"

showing 10 items of 11 documents

Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria?

2021

Background and purpose The aim was to identify the clinical and diagnostic investigations that may help to support a diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in patients not fulfilling the European Federation of Neurological Societies and Peripheral Nerve Society (EFNS/PNS) electrodiagnostic criteria. Methods The data from patients with a clinical diagnosis of CIDP included in a national database were retrospectively reviewed. Results In all, 535 patients with a diagnosis of CIDP were included. This diagnosis fulfilled the EFNS/PNS criteria in 468 patients (87.2%) (definite in 430, probable in 33, possible in three, while two had chronic immune sensory p…

Pediatricsmedicine.medical_specialtyResponse to therapyDatabases FactualNeural ConductionSettore MED/2603 medical and health sciences0302 clinical medicinePeripheral nerveRetrospective StudieMedicineHumansMedical historyIn patient030212 general & internal medicinePeripheral NervesRetrospective Studieschronic inflammatory demyelinating polyradiculoneuropathybusiness.industryPolyradiculoneuropathyPolyradiculopathymedicine.diseaseelectrophysiologySettore MED/26 - NEUROLOGIANeurologyPolyradiculoneuropathy Chronic Inflammatory DemyelinatingClinical diagnosisPeripheral Nervediagnostic criteriaNational databaseNeurology (clinical)chronic inflammatory demyelinating polyradiculoneuropathy; diagnostic criteria; electrophysiologybusiness030217 neurology & neurosurgeryHuman
researchProduct

Les réadmissions après résection pulmonaire en France : la base de données du PMSI

2021

BACKGROUND Readmission within 30 days is an indicator of the quality of care, because it often reflects post-discharge care that is not optimal. The objective of this work is to measure over time on the one hand the readmission rate and on the other hand the number of hospitals with a standardized readmission rate beyond the national average. METHOD All patients with major pulmonary resection for lung cancer in France were extracted from the PMSI national database. Readmission within 30 days was defined as any new hospitalization either in the same hospital or in another establishment. RESULTS From January 1, 2005 to December 31, 2018, 110,603 patients were included. The 30-day all-cause re…

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industrymedicine.medical_treatmentmedicine.diseaseReadmission rate3. Good health03 medical and health sciencesPneumonectomy0302 clinical medicine030228 respiratory systemEmergency medicinemedicineNational database030212 general & internal medicineNational averageLung resectionPulmonary resectionQuality of careLung cancerbusinessRevue des Maladies Respiratoires
researchProduct

Évaluation de la pratique chirurgicale dans le traitement du cancer bronchique en France à partir de la base nationale du PMSI

2019

Background - In recent years, improving the quality of care has been a concern for health professionals in France, through the certification of institutions, accreditation and continuous professional development. Evaluation of these different measures has rarely been carried out. The objective of the study was to evaluate the quality of surgical management of lung cancer in different regions using hospital mortality as an indicator. Method - From the national database of the Program of Medical Information Systems (PMSI), data on all patients who had undergone surgery for lung cancer were extracted as well as the characteristics of the centers. The main outcome criterion was hospital mortali…

Pulmonary and Respiratory MedicineVolume d’activitésmedicine.medical_specialtyGrippe[SDV.CAN]Life Sciences [q-bio]/CancerEpidémie saisonnière03 medical and health sciences0302 clinical medicineHospital volumeBase de données nationales médico-administrative[SDV.CAN] Life Sciences [q-bio]/Cancermedicine030212 general & internal medicineChirurgieGynecologybusiness.industryRisk standardized rate of mortalityPMSI3. Good healthHospital volumeTaux standardisé de mortalité030228 respiratory systemCancer du poumonNational databaseFranceLung cancerbusinessHôpitalSurgery Medico-administrative database
researchProduct

Idursulfase treatment of Hunter syndrome in children younger than 6 years: results from the Hunter Outcome Survey.

2011

Purpose: To use the Hunter Outcome Survey, an international database, to assess the safety and effectiveness of enzyme replacement therapy with idursulfase in patients with Hunter syndrome who started treatment before 6 years of age. Methods: The study population included all patients enrolled in the Hunter Outcome Survey who started idursulfase infusions (0.5 mg/kg every other week) before 6 years of age and who had at least one follow-up examination recorded. Results: The study population included 124 patients, younger than 6 years, who had a mean age at start of idursulfase of 3.6 ± 1.6 years (mean ± SD). The mean duration of treatment was 22.9 ± 14.6 months. A total of 69 infusion-relat…

AdultPediatricsmedicine.medical_specialtyAdolescentDatabases FactualIdursulfaseUrineIduronate Sulfatasechemistry.chemical_compoundYoung AdultInternational databaseMedicineHumansEnzyme Replacement TherapyYoung adultChildInfusions IntravenousGenetics (clinical)GlycosaminoglycansMucopolysaccharidosis IICreatinineClinical Trials as Topicbusiness.industryData CollectionInfantHunter syndromeEnzyme replacement therapymedicine.diseaseTreatment OutcomechemistryChild PreschoolPopulation studybusinessmedicine.drugGenetics in medicine : official journal of the American College of Medical Genetics
researchProduct

Clusters of sleep apnoea phenotypes: A large pan-European study from the European Sleep Apnoea Database (ESADA)

2021

Background and objective: To personalize OSA management, several studies have attempted to better capture disease heterogeneity by clustering methods. The aim of this study was to conduct a cluster analysis of 23 000 OSA patients at diagnosis using the multinational ESADA. Methods: Data from 34 centres contributing to ESADA were used. An LCA was applied to identify OSA phenotypes in this European population representing broad geographical variations. Many variables, including symptoms, comorbidities and polysomnographic data, were included. Prescribed medications were classified according to the ATC classification and this information was used for comorbidity confirmation. Results: Eight cl…

MalePulmonary and Respiratory MedicineDatabases FactualTreatment adherenceinternational databaseComorbidityDiseasecomputer.software_genre03 medical and health sciencesSleep Apnea Syndromes0302 clinical medicinePan europeanHumansMedicinecluster analysis ; international database ; personalized medicine ; phenotypes ; sleep apnoea.030212 general & internal medicineMedical prescriptionPrescribed medicationsComputingMilieux_MISCELLANEOUSSleep Apnea Obstructive[STAT.AP]Statistics [stat]/Applications [stat.AP]Databasebusiness.industryphenotypesEuropean populationpersonalized medicinemedicine.diseaseComorbidity3. Good healthPhenotype030228 respiratory systemFemalePersonalized medicinebusinesscomputersleep apnoea[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologycluster analysis
researchProduct

Fibromyalgia severity according to age categories: results of a cross-sectional study from a large national database

2021

ObjectiveThe role of age in influencing the severity of fibromyalgia (FM) is still controversial. The aim of this study is to define the contribution of age in the severity of FM from data from a large national database.MethodsThis cross-sectional study included adult patients with FM diagnosed according to the 2010/2011 American College of Rheumatology criteria. Disease severity was assessed with the revised Fibromyalgia Impact Questionnaire (FIQR) and the modified Fibromyalgia Assessment Status (FAS 2019mod). Patients were grouped into five age categories (between 18-40 years, between 41- 50 years, between 51-60 years, between 61-70 years, and =71 years). Differences in disease severity b…

AdultMaleSettore MED/16 - REUMATOLOGIAAdolescentImmunologyReproducibility of ResultsMiddle AgedFAS 2019mod.Severity of Illness IndexYoung AdultCross-Sectional StudiesRheumatologyagenational databaseSurveys and QuestionnairesQuality of LifeImmunology and AllergyHumansdisease severityFemalefibromyalgiaFIQR
researchProduct

Time-to-cure and cure proportion in solid cancers in France. A population based study.

2019

In cancer care, the cure proportion (P) and time-to-cure (TTC) are important indicators for practitioners, patients, and healthcare policy makers. The recent definition of TTC as the time at which the probability of belonging to the cured group reaches 95% was used for the first time.The data stem from the common database of French cancer registries including 335,358 solid tumours diagnosed between 1995 and 2009 at 27 sites. P and TTC were estimated through a flexible parametric net survival cure model for each cancer site, sex, and age at diagnosis with acceptable assumption of cure (excess mortality rate ≤0.05).TTC was ≤5 years and P was80% for skin melanoma and thyroid and testis cancers…

AdultMaleCancer Researchmedicine.medical_specialtyDatabases FactualEpidemiology[SDV]Life Sciences [q-bio]03 medical and health sciences0302 clinical medicineInternal medicineNeoplasmsEpidemiologymedicineHumanscardiovascular diseases030212 general & internal medicineRegistriesNet SurvivalThyroid cancerAgedbusiness.industryThyroidCancerMiddle Agedmedicine.disease3. Good healthPopulation based studySurvival Ratemedicine.anatomical_structureOncology030220 oncology & carcinogenesisNational databaseFemaleFranceSkin melanomabusinessCancer epidemiology
researchProduct

International database on human capital quality

2007

In this research work, we have used a methodology which enables us to obtain qualitative indicators of human capital (QIHC) for 105 countries. This methodology relies on the potential to reconsider survey results comparatively by analysing the results of countries which took part in at least two different surveys. This allowed us to build indicators of comparable data concerning the quality of human capital in numerous countries and between 1964-2005: our results represent a valuable comparison to what has been done so far.

Economics and EconometricsEconomic growth[SHS.EDU]Humanities and Social Sciences/EducationAnalyse macroéconomiqueQualité de l'éducationmedia_common.quotation_subject[SHS.EDU] Humanities and Social Sciences/EducationCapital humainHuman capitalInternational databaseRegional scienceHuman capital[ SHS.ECO ] Humanities and Social Sciences/Economies and financesEducation qualityQuality (business)[SHS.ECO] Humanities and Social Sciences/Economics and FinanceIndicateur de qualitémedia_commonEducational QualityMacroeconomic data[ SHS.EDU ] Humanities and Social Sciences/EducationDonnées macro-économiques[SHS.ECO]Humanities and Social Sciences/Economics and FinanceDonnées macro-économiquesQualité de l'éducationCapital humainIndicateur de qualitéMacroeconomic DataEducational QualityHuman CapitalGeographyFinanceEconomics Letters
researchProduct

274 Comparative analysis of patients with acute coronary and cerebrovascular syndromes from the national French hospitalisation heath care system dat…

2011

Objective To compare vascular risk factor profiles and early outcomes in all French patients hospitalized for either acute coronary (ACS), or cerebrovascular syndromes (CVS), or both, between 2005 and 2008. Setting All French hospitals. Design Retrospective analysis. Data sources National database called “Hospital Discharge Diagnosis Records”. Main outcomes measured Number and annual rates, vascular risk factors, and early outcome of hospitalized patients for a unique stay for ACS or CVS or for both ACV and CVS in a 2-month time window. Results Over the 4-year study-period, 1,189,043 patients were hospitalized for CVS and/or ACS. Among these, 638,061 (53.7%) had CVS alone, 525,419 (44.3%) h…

medicine.medical_specialtybusiness.industryAbsolute risk reductionEarly deathAtrial fibrillationVascular riskmedicine.diseaseTime windowsDiabetes mellitusInternal medicineHospital dischargemedicineNational databasebusinessCardiology and Cardiovascular MedicineArchives of Cardiovascular Diseases Supplements
researchProduct

225 Comparative analysis of patients with acute coronary and cerebrovascular syndromes from the national French hospitalisation heath care system dat…

2011

ObjectiveTo compare vascular risk factor profiles and early outcomes in all French patients hospitalized for either acute coronary (ACS), or cerebrovascular syndromes (CVS), or both, between 2005 and 2008.SettingAll French hospitals.DesignRetrospective analysis.Data sourcesNational database called “Hospital Discharge Diagnosis Records”.Main outcomes measuredNumber and annual rates, vascular risk factors, and early outcome of hospitalized patients for a unique stay for ACS or CVS or for both ACV and CVS in a 2-month time window.ResultsOver the 4-year study-period, 1,189,043 patients were hospitalized for CVS and/or ACS. Among these, 638,061 (53.7%) had CVS alone, 525,419 (44.3%) had ACS alon…

Pediatricsmedicine.medical_specialtybusiness.industryAbsolute risk reductionAtrial fibrillationEarly deathVascular riskmedicine.diseaseTime windowsInternal medicineDiabetes mellitusHospital dischargeMedicineNational databasebusinessCardiology and Cardiovascular MedicineArchives of Cardiovascular Diseases Supplements
researchProduct